Pneumonia in the developed world

Paediatric Respiratory Reviews

Volumn 12, Issue 1, 2011, Pages 60-69

  Prayle, Andrew ^a   Atkinson, Maria ^b   Smyth, Alan ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Antibiotic; Child; Developed Countries; Management; Pneumonia

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; C REACTIVE PROTEIN; CEFPODOXIME PROXETIL; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; METHYLPREDNISOLONE; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; PROCALCITONIN;

ANTIBIOTIC RESISTANCE; BACTERIAL PNEUMONIA; BLOOD CULTURE; BOCAVIRUS; BRONCHOPLEURAL FISTULA; CLINICAL TRIAL; COUGHING; DEVELOPED COUNTRY; DISEASE SEVERITY; DRUG CHOICE; ELECTROLYTE DISTURBANCE; FEVER; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; HUMAN METAPNEUMOVIRUS; INCIDENCE; INFLUENZA A (H1N1); LEUKOCYTE COUNT; MORTALITY; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NASOPHARYNGEAL ASPIRATION; PLEURA EMPYEMA; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; THROAT CULTURE; TREATMENT DURATION; VIRUS PNEUMONIA; WHEEZING;

CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; HUMANS; INFANT; PNEUMONIA;

EID: 78650229993     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2010.09.012     Document Type: Review

References (66)

1. IMF. WEO groups and aggregates information. Interntaional Monetary Fund; 2009 [updated 2009; cited 2010 7th April]; Available from: http://www.imf.org/external/pubs/ft/weo/2009/02/weodata/groups.htm%23ae.
2. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002 Feb 7, 346:429-437.
3. Myles P.R., McKeever T.M., Pogson Z., Smith C.J., Hubbard R.B. The incidence of pneumonia using data from a computerized general practice database. Epidemiol Infect 2009 May, 137:709-716.
4. Senstad A.C., Suren P., Brauteset L., Eriksson J.R., Hoiby E.A., Wathne K.O. Community-acquired pneumonia (CAP) in children in Oslo. Norway. Acta Paediatr 2009 Feb, 98:332-336.
5. Roxburgh C.S., Youngson G.G., Townend J.A., Turner S.W. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 2008 Apr, 93:316-318.
6. Myles P.R., Hubbard R.B., Gibson J.E., Pogson Z., Smith C.J., McKeever T.M. Pneumonia mortality in a UK general practice population cohort. Eur J Public Health 2009 Oct, 19:521-526.
7. Lahti E., Peltola V., Waris M., et al. Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax 2009 Mar, 64:252-257.
8. Ng V., Tang P., Jamieson F., et al. Going with the flow: legionellosis risk in Toronto, Canada is strongly associated with local watershed hydrology. Ecohealth 2008 Dec, 5:482-490.
9. Neil K., Berkelman R. Increasing incidence of legionellosis in the United States, 1990-2005: changing epidemiologic trends. Clin Infect Dis 2008 Sep 1, 47:591-599.
10. Ng V., Tang P., Jamieson F., Guyard C., Low D.E., Fisman D.N. Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006. BMC Infect Dis 2009, 9:68.
11. CDCC. Increase in Coccidioidomycosis - California, 2000-2007. MMWR Morb Mortal Wkly Rep 2009 Feb 13;58(5):105-9.
12. Foy H.M. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993 Aug, 17(Suppl 1):S37-S46.
13. Murphy C.G., van de Pol A.C., Harper M.B., Bachur R.G. Clinical predictors of occult pneumonia in the febrile child. Acad Emerg Med 2007 Mar, 14:243-249.
14. Mathews B., Shah S., Cleveland R.H., Lee E.Y., Bachur R.G., Neuman M.I. Clinical predictors of pneumonia among children with wheezing. Pediatrics 2009, 124:e29-36.
15. Craig J.C., Williams G.J., Jones M., et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ 2010, 340:c1594.
16. Virkki R., Juven T., Rikalainen H., Svedstrom E., Mertsola J., Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax 2002 May, 57:438-441.
17. BTS Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002 May 2002; 57(suppl 1):i1-i24.
18. Korppi M., Don M., Valent F., Canciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr 2008 Jul, 97:943-947.
19. Don M., Valent F., Korppi M., Canciani M. Differentiation of bacterial and viral community-acquired pneumonia in children. Pediatr Int 2009 Feb, 51:91-96.
20. Khan D.A., Rahman A., Khan F.A. Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children?. J Clin Lab Anal 2010, 24(1):1-5.
21. Hamano-Hasegawa K., Morozumi M., Nakayama E., et al. Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemother 2008 Dec, 14:424-432.
22. Rello J., Lisboa T., Lujan M., et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009 Sep, 136:832-840.
23. Cheong H.F., Ger L.P., Wu M.T., et al. Clinical application of the rapid pneumococcal urinary antigen test in the treatment of severe pneumonia in children. J Microbiol Immunol Infect 2008 Feb, 41:41-47.
24. Crocker K., Cramer B., Hutchinson J.M. Antibiotic availability and the prevalence of pediatric pneumonia during a physicians' strike. Can J Infect Dis Med Microbiol 2007 May, 18:189-192.
25. Friis B., Andersen P., Brenoe E., et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984 Nov, 59:1038-1045.
26. Clark J.E., Hammal D., Spencer D., Hampton F. Children with pneumonia: how do they present and how are they managed?. Arch Dis Child 2007 May, 92:394-398.
27. Tsarouhas N., Shaw K.N., Hodinka R.L., Bell L.M. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia. Pediatr Emerg Care 1998 Oct, 14:338-341.
28. Atkinson M., Lakhanpaul M., Smyth A., et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax 2007 Dec, 62:1102-1106.
29. Lorgelly P.K., Atkinson M., Lakhanpaul M., et al. Oral versus IV antibiotics for CAP in children: a cost minimisation analysis. Eur Respir J 2009 Aug 28.
30. Roord J.J., Wolf B.H., Gossens M.M., Kimpen J.L. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. Antimicrob Agents Chemother 1996 Dec, 40:2765-2768.
31. Block S., Hedrick J., Hammerschlag M.R., Cassell G.H., Craft J.C. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995 Jun, 14:471-477.
32. Jones B., Jarvis P., Lewis J.A., Ebbutt A.F. Trials to assess equivalence: the importance of rigorous methods. BMJ. 1996 Jul 6, 313:36-39.
33. Harris J.A., Kolokathis A., Campbell M., Cassell G.H., Hammerschlag M.R. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998 Oct, 17:865-871.
34. Wubbel L., Muniz L., Ahmed A., et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999 Feb, 18:98-104.
35. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008(2):CD005976.
36. Peltola H., Vuori-Holopainen E., Kallio M.J. Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. Int J Infect Dis. 2001, 5(1):3-8.
37. Tamura A., Matsubara K., Tanaka T., Nigami H., Yura K., Fukaya T. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008 Sep, 57:223-228.
38. Felmingham D., Farrell D.J., Reinert R.R., Morrissey I. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000). J Infect 2004 Jan, 48:39-55.
39. EARSS. EARSS Annual Report 2008. EARSS, Bilthoven, The Netherlands, October 2009. Report number: RIVM: 210624003.
40. Wexler I.D., Knoll S., Picard E., et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol 2006 Aug, 41:726-734.
41. Tan T.Q., Mason E.O., Barson W.J., et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998 Dec, 102:1369-1375.
42. Hodina M., Hanquinet S., Cotting J., Schnyder P., Gudinchet F. Imaging of cavitary necrosis in complicated childhood pneumonia. Eur Radiol 2002 Feb, 12:391-396.
43. Sawicki G.S., Lu F.L., Valim C., Cleveland R.H., Colin A.A. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J 2008 Jun, 31:1285-1291.
44. Strachan R., Jaffe A. Assessment of the burden of paediatric empyema in Australia. J Paediatr Child Health 2009, 45:431-436.
45. Li S.T., Tancredi D.J. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010 Jan, 125(1):26-33.
46. CDCC Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 2008 Feb 15;57(6):144-8.
47. Albrich W.C., Baughman W., Schmotzer B., Farley M.M. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007 Jun 15, 44:1569-1576.
48. Diep B.A., Chan L., Tattevin P., et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010 Mar, 107(12):5587-5592.
49. Thomas B., Pugalenthi A., Chilvers M. Pleuropulmonary complications of PVL-positive Staphylococcus aureus infection in children. Acta Paediatr 2009 Aug, 98:1372-1375.
50. Cunnington A., Brick T., Cooper M., et al. Severe invasive Panton-Valentine Leucocidin positive Staphylococcus aureus infections in children in London. UK. J Infect 2009, 59:28-36.
51. CDCC Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR Morb Mortal Wkly Rep 2010 Apr 16;59(14):423-30.
52. Miroballi Y., Baird J.S., Zackai S., et al. Novel influenza A(H1N1) in a pediatric health care facility in New York City during the first wave of the 2009 pandemic. Arch Pediatr Adolesc Med 2010 Jan, 164(1):24-30.
53. Diavatopoulos D.A., Short K.R., Price J.T., et al. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J 2010 Jan, 22.
54. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001 Jun, 7:719-724.
55. Wolf D.G., Greenberg D., Shemer-Avni Y., Givon-Lavi N., Bar-Ziv J., Dagan R. Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr 2010 Jan, 156:115-120.
56. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005 Sep 6, 102:12891-12896.
57. Schildgen O., Muller A., Allander T., et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections?. Clin Microbiol Rev 2008 Apr, 21:291-304.
58. Don M., Soderlund-Venermo M., Valent F., et al. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 2010 Feb, 45:120-126.
59. Don M., Valerio G., Korppi M., Canciani M. Hyponatremia in pediatric community-acquired pneumonia. Pediatr Nephrol 2008 Dec, 23:2247-2253.
60. Mahmood D., Vartzelis G., McQueen P., Perkin M.R. Radiological follow-up of pediatric pneumonia: principle and practice. Clin Pediatr (Phila) 2007 Mar, 46:160-162.
61. Eastham K.M., Hammal D.M., Parker L., Spencer D.A. A follow-up study of children hospitalised with community-acquired pneumonia. Arch Dis Child 2008 Sep, 93:755-759.
62. Smyth A.R., Barbato A., Beydon N., et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 2010 Feb, 35:247-265.
63. Tajima T., Nakayama E., Kondo Y., et al. Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. J Infect Chemother 2006 Dec, 12:372-379.
64. Clark J.E., Hammal D., Hampton F., Spencer D., Parker L. Epidemiology of community-acquired pneumonia in children seen in hospital. Epidemiol Infect 2007 Feb, 135:262-269.
65. Clements H., Stephenson T., Gabriel V., et al. Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child 2000 Oct, 83:320-324.
66. Klein M. Multicenter trial of cefpodoxime proxetil vs. amoxicillin-clavulanate in acute lower respiratory tract infections in childhood. International Study Group. Pediatr Infect Dis J 1995 Apr, 14(4 Suppl):S19-S22.